跳转至内容
Merck
CN

51100AST

Astec® Cellulose DMP Chiral (5 μm) HPLC Column

L × I.D. 15 cm × 2.1 mm, HPLC Column

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
15 cm × 2.1 mm
Particle size:
5 μm
Matrix active group:
cellulose, DMPC- phase
Pore size:
100 Å pore size
Matrix:
fully porous particle, silica gel high purity, spherical, silica gel particle platform
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

Astec ® 纤维素 DMP 手性 HPLC 色谱柱, 5 μm particle size, L × I.D. 15 cm × 2.1 mm

Quality Level

material

stainless steel column

agency

suitable for USP L40

product line

Astec®

packaging

pkg of 1 ea

manufacturer/tradename

Astec®

parameter

0-40 °C temperature, 50 bar pressure (725 psi)

technique(s)

HPLC: suitable

L × I.D.

15 cm × 2.1 mm

matrix

fully porous particle, silica gel high purity, spherical, silica gel particle platform

matrix active group

cellulose, DMPC- phase

particle size

5 μm

pore size

100 Å pore size

operating pH

3.5-6.8

separation technique

chiral

General description

Astec®纤维素 DMP HPLC 色谱柱在正相、极性有机和 SFC 条件下分离多种手性化合物。它们具有高效率、高负载能力和极好的色谱柱使用寿命。Astec®纤维素DMP具有与其他DMPC衍生的纤维素CSP相当的性能,但价格却低得多,是每个手性色谱柱HPLC或SFC筛选方案的必备必备成分。Astec ® 纤维素 DMP 与其他 Astec ® CSP 互补,包括 CHIROBIOTIC ®、CYCLOBOND 和 P-CAP 产品线。

描述:球形多孔二氧化硅,涂有DMPC(氨基甲酸二甲基苯酯)衍生的纤维素
颗粒直径:5μm
使用范围: 正相、极性有机和 SFC 模式下的小分子对映异构体分离

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
P-CAP is a trademark of Sigma-Aldrich Co. LLC


Still not finding the right product?




历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

Separate a wide range of chiral compounds via normal phase, polar organic, and SFC conditions; useful in pharma, chemical, & environmental industry applications.

Efficient, Rugged, and Economical Columns for Chiral HPLC & SFC


Katrijn De Klerck et al.
Journal of pharmaceutical and biomedical analysis, 69, 77-92 (2012-03-01)
Chirality has a significant impact on drug discovery and development processes in the pharmaceutical industry. As the number of enantiopure drugs launched onto the market is yearly increasing, the need for fast and performant enantioseparation methods with minimal costs is
Katrijn De Klerck et al.
Journal of chromatography. A, 1328, 85-97 (2014-01-21)
Since their introduction on the market the applicability of immobilized polysaccharide-based chiral stationary phases in high-performance liquid chromatography has been thoroughly investigated. These immobilized phases have the benefit to be applicable with a wide range of modifiers, potentially extending the



全球贸易项目编号

货号GTIN
51100AST04061833363676